NC
MDXG icon

nVerses Capital’s MiMedx Group MDXG Stock Holding History

nVerses Capital’s Portfolio MDXG Stock Details MDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-54,022
Closed -$366K – 428
2025
Q4 		$366K Buy
+54,022
New +$379K 0.82% 16
2024
Q4 		– Sell
-300
Closed -$1.77K – 514
2024
Q3 		$1.77K Buy
+300
New +$1.99K ﹤0.01% 955

Other funds holding MDXG

EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

nVerses Capital's MDXG Position: Q1 2026 in Review

nVerses Capital sold out of MiMedx Group (MDXG) in Q1 2026, closing a stake of 54,022 shares — an estimated $366K sold.

nVerses Capital first reported a position in MDXG in Q3 2024 and held it in 2 quarters. The position peaked at $366K in Q4 2025. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.

  • nVerses Capital reported no remaining MiMedx Group position as of Q1 2026 after selling out during the quarter.
  • nVerses Capital sold 54,022 MiMedx Group shares in Q1 2026, an estimated $366K.
  • nVerses Capital first reported a position in MiMedx Group in Q3 2024 and held it in 2 quarters.
  • nVerses Capital's MiMedx Group position peaked at $366K in Q4 2025.
  • 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.

Based on nVerses Capital's 13F filing for Q1 2026, filed 13 May 2026.